Monday, 20 March 2017

Tear supplements

Currently, tear supplements are available as solutions, ointments and gels. They can be used as often as necessary to keep the corneal surface and conjunctiva wet. Preferably, the topical application of a well-formulated tear supplement and lubricating agent should provide relief for both aqueous- and mucin-deficient dry eye. Moreover, functions associated with the lipid layer of the precorneal tear film should not be altered by the tear supplement.

There are several objectives that tear supplements aim to fulfil in the treatment of dry eye.

Objectives of tear supplements

Ideally, tear supplements should fulfil the physico-chemical role of a normal tear film. In addition, they should not disturb corneal metabolism nor be toxic to the eye, even with frequent use. It should also have a refractive index similar to that of the cornea to see correctly. This involves consideration of certain characteristics in the formulation if tear supplements are to resemble physiological tears. These include electrolyte concentration, viscosity, mucomimetic properties, pH, osmolarity and the absence of preservatives. 

Your can read more about this subject here: 

Thursday, 4 August 2016

Would you like to work for TRB Chemedica?

TRB Chemedica (UK) Ltd is currently recruiting four Graduate Sales Representatives in the South of England. You must have a life sciences degree, particularly in Biology, Medical, Pharmacology, Pharmacy, Chemistry, Nursing, Sports Science, or relevant experience in the field, with excellent language and presentation skills. You will be selling our rheumatology and ophthalmic products to customers in the NHS and private practice. 

If you think you’re the right person for us then please send your CV to

For more information please also visit our website

Wednesday, 8 June 2016

Most Common Cause of Dry Eye: Meibomian Gland​ Dysfunction

Meibomian glands help to form the superficial layer of fat on the tear film. This reduces the evaporation of the tear fluid, improves stability, protects the surface of the eye and is essential for good visual function. Meibomian Gland Dysfunction (MGD) can lead to dry eye due to increased evaporation. MGD is thus responsible for approximately 60 % of all cases of dry eye alone and for a further 20 % of cases associated with a deficiency in the aqueous tear film phase.

Meibomian Gland Dysfunction (MGD) can therefore be considered as the most common cause of dry eye.

Baudouin et al. presented a new pathological diagram of MGD in an attempt to give a clearer picture of the basic mechanisms involved in the development and interaction of dry eye. It should facilitate a more effective treatment of MGD and dry eye in clinical practice 1:
To continue to read this informative article please click on the link here:

1. Baudouin C, Messmer EM, Aragona P, Geerling G, Akova YA, Benítez-Del-Castillo J, Boboridis KG, Merayo-Lloves J, Rolando M, Labetoulle M. Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction. Br J Ophthalmol. 2016 May;100(3):300-6

Monday, 16 May 2016

OSTENIL is #injectionofoil 

In a Twitter conversation this weekend, former Premiership footballer, Don Hutchison, recommended OSTENIL as a "god send" [sic] and as "#injectionofoil":

Thank you for the commendation, and best wishes to you!

Monday, 15 February 2016

New Guidelines Offer Hope for Older UK Osteoarthritis Sufferers

A report on how people suffering with symptomatic Osteoarthritis (OA) of the knee may still be able to remain active in sport has just been published in the Clinical Journal of Sport Medicine. Clinical Journal of Sport Medicine: January 2016 - Volume 26 - Issue 1 - p 1–11 doi: 10.1097/JSM.0000000000000274
The authors – who are all members of The American Medical Society for Sport Medicine (AMSSM), an organisation which represents over 2100 nonsurgical sports medicine physicians - carried out a detailed meta-analysis (a process where the results of many different studies are pooled and then subjected to sensitive statistical testing) of all relevant clinical investigations relating to the use of Viscosupplementation published between 1960 and 2014.  Viscosupplementation is an internationally recognised treatment modality for Osteoarthritis of the knee. The process involves injecting Hyaluronic Acid (HA) or Sodium Hyaluronate as it is often referred to, directly into the affected joint. HA is a viscous fluid which closely resembles the natural synovial fluid found in all healthy articular joints...

Wednesday, 15 October 2014

Improved VISMED MULTI OSD Bottle

The award-winning OSD bottle we use for VISMED MULTI and VISMED GEL MULTI has recently been updated. This comes as a result of our policy of ongoing improvement to products and procedures. We listened to our customers and patients who were ...asking for some amendments to the OSD bottle and this is what has been achieved:

- Release strength reduced by 25% - 30%.
- The new type bottle now feels the same at half empty as the old style when completely full.
- The bottle can be emptied more easily due to a better drop control.

You can read more about it here:

Monday, 14 July 2014

Efficacy of Hypotonic 0.18% Sodium Hyaluronate Eye Drops in Patients With Dry Eye Disease

The above is the title of a new study by Lee HS et al, published in June 2014. "Hypotonic 0.18% SH eye drops seemed to be effective in improving tear film stability and ocular surface integrity compared with isotonic 0.1% SH eye drops in patients with mild DED."

The abstract can be viewed here: